Congenital Clouding of the Cornea Workup

  • Author: Noah S Scheinfeld, MD, JD, FAAD; Chief Editor: Hampton Roy Sr, MD   more...
 
Updated: Jul 22, 2011
 

Laboratory Studies

  • Corneal clouding is a clinical and not a laboratory finding unless it is due to mucopolysaccharidoses.
  • If MPS VI is suspected, quantification of glycosaminoglycans (GAGs) in the urine and measurement of N -acetylgalactosamine-4-sulfatase (ARSB) activity in leukocytes may be warranted.
  • In addition to the mucopolysaccharidoses, the differential diagnosis of bilateral corneal stromal opacification includes HDL-deficiency diseases (eg, LCAT deficiency, Tangier disease, fish-eye disease), Schnyder crystalline stromal dystrophy, cystinosis, gout, and mucolipidoses. Scheie syndrome (MPS I S) may easily be detected by finding alpha-L-iduronidase deficiency in leukocytes and increased mucopolysaccharide levels in the urine.
Next

Imaging Studies

  • The following imaging studies may be performed depending on the physical findings to assess for conditions that may accompany corneal clouding:
    • Newborn PCG can be recognized at birth because of the associated corneal opacification. The evaluation of congenital glaucoma should include the following: a complete eye examination, including anterior segment evaluation, with slit lamp biomicroscopy, funduscopy, tonometry, and gonioscopy. Ocular examination of a patient with congenital glaucoma can reveal anterior segment abnormalities of the cornea, iris, and filtration angle as well as related elevated IOP. A-scan ultrasonography can reveal an enlarged globe (buphthalmos). Genetic analysis can be done to detect syndromes associated with congenital glaucoma.
    • Indirect gonioscopy can be performed with a Goldmann lens. IOP can be measured with a Goldmann applanation tonometer. Photographs can be taken of the anterior segment and all 4 quadrants of the iridocorneal angle to record the presence of abnormalities. The iridocorneal angle can be graded according to the classification proposed by Spaeth.
    • Photoscreening is designed to detect abnormalities in children's eyes, particularly abnormal refractive errors, which can lead to amblyopia. Photoscreening can also detect congenital glaucoma.
    • Tonometry is an essential component of the examination but can be the most difficult part of the examination with a fractious child.
    • Inspection and examination of the anterior segment are facilitated by the use of a penlight and a handheld slit lamp, which allow maneuverability regardless of the child's position.
    • The optic nerve head may be examined with a direct or indirect ophthalmoscope.
    • MRI of the abdomen is indicated to rule out genitourinary abnormalities.
    • MRIs of the brain and spinal cord are also indicated to rule out neurologic defects.
    • Echocardiography is indicated to rule out cardiac defects.
    • Ocular ultrasonography may be useful in assessing other ocular abnormalities. This includes patients with type II and VI mucopolysaccharidosis (MPS) in whom clinically marked corneal clouding is present; measuring the corneal thickness can evaluate intraocular pressure and possible coexistent glaucoma.[22]
    • Ultrasound biomicroscopy (UBM) is often helpful in the evaluation of anterior segment structures that cannot be observed clearly because of the corneal opacity. UBM and histopathology can play a role in the evaluation of sclerocornea.[23]
    • B-scan ultrasonography is necessary to evaluate the posterior segment if the corneal opacity is dense and central.
    • CT scanning is indicated to help diagnose protuberant congenital corneal opacities.
Previous
Next

Other Tests

  • Hearing tests may be performed to rule out hearing abnormalities.
  • Corneal clouding, as observed by using a slit lamp, may be used in the differential diagnosis of mucopolysaccharidoses. Corneal clouding is present in MPS I, VI, and VII but absent in MPS II.
Previous
Next

Procedures

  • Maroteaux-Lamy syndrome (MPS VI) can be evaluated by means of slit lamp biomicroscopy, Orbscan II slit scanning elevation topography, and in vivo confocal microscopy.
  • Slit lamp biomicroscopy can reveal bilateral, altered corneal transparency involving the posterior half of the stroma.
  • Funduscopy reveals bilateral small, crowded optic discs, and radial macula retinal folds.
  • On in vivo confocal microscopy, the middle and posterior stroma can be visualized and show well-defined, unusually shaped keratocytes. These cells contain single or several hyporeflective regions with well-defined borders 1-11.6 micrometers in diameter. These abnormal keratocytes are particularly abundant in the posterior stroma and sparse in the anterior stroma.
Previous
Next

Histologic Findings

Histopathologic results are often diagnostic for Peters anomaly. Histologic findings show either thinning or absence of the Descemet membrane or the endothelium. The lens may be normal, or it may be cataractous and adhere to the cornea. The stromal lamellae are irregular and more closely packed. Undifferentiated iris strands attach to the posterior surface of the cornea.

Perry states, "Histopathologic findings include absence of Descemet's membrane, corneal endothelium, and, usually, Bowman's membrane, as well as thinning of corneal stroma. The defects in Descemet's membrane, although usually single and central, may be multiple and isolated to the periphery, or they may be limited to an area of adhesion of iris. Descemet's membrane has been found to have embryonal ultrastructural characteristics combined with attenuated endothelium. The corneal stromal lamellae are more irregular and closely packed when compared to normal stromal lamella."[7]

Histochemical studies have shown absence of keratan sulfate in both the cornea and the sclera.

Immunohistochemical studies have shown increased amounts of fibronectin and type VI collagen in the corneas of patients with Peters anomaly.

In MPS VI B, the histopathologic and ultrastructural features of the corneal button reveal the accumulation of membrane-bound vacuoles containing fibrillogranular and lamellated material in keratocytes and endothelial cells and thinning of the Descemet membrane with excrescences. Other MPS diseases can have other histologic findings.

A 4-month-old male infant with severe corneal opacity since birth had buphthalmos, increased IOP, and corneal opacity with neovascularization.[21] (See Clinical variant of Sanfilippo syndrome in History.) Histopathologic examination of the corneal button showed homogeneous thickening of the Bowman layer and pinkish intracytoplasmic substances in the corneal stroma. The Alcian blue stain was positive, consistent with MPS of the cornea. The manifestation of this case may be a clinical variant of Sanfilippo syndrome (MPS III).

In sclerocornea, the numbers of collagen fibrils are increased and their diameter varies in the normal corneal stroma. The Descemet membrane appears thin. Scleralization of the collagen fibrils often stops in the pre-Descemet membrane region, permitting deep lamellar keratoplasty.

In cornea plana, the corneal tissue is histologically normal. The axial length of eyes that contain cornea plana is normal.

Perry notes that, in corneal keloids, "Stromal nodules are composed of proliferating myofibroblasts, activated fibroblasts, and haphazardly arranged fascicles of collagen. Immunohistochemical stains show spindle cells that express immunoreactivity for vimentin and alpha smooth muscle actin. Keloid formation may be the result of excessive local delivery of amino acids and unknown noxious substances through leaking corneal vessels."[7]

Perry notes that, in corneal dermoids, "Histologically, the corneal epithelium may be keratinized. Bowman's membrane often is absent. The stroma is replaced to a variable degree by irregularly arranged, dense, vascularized, collagenous connective tissue containing hair follicles, hair shafts, sebaceous glands, fat, smooth muscle, striated muscle, cartilage, teeth, or bone. The mass may be either cystic or solid."[7]

Perry notes that, in congenital corneal ectasia, "Histologically, the corneal epithelium has normal thickness but may be keratinized secondary to exposure. Often, local attenuation of Bowman's membrane occurs. The stroma is thickened, disorganized, hypercellular, and vascularized. A double layer of pigment-containing cells lines the posterior corneal stroma. Usually, no sign of an inflammatory infiltrate is present. Descemet's membrane and corneal endothelium are absent."[7]

Perry notes that, in congenital hereditary stromal dystrophy, "The collagen of the corneal stroma by electron microscopy consists of alternating layers of small-diameter collagen fibrils of approximately one-half the normal fibril diameter. Also, the anterior banded portion of Descemet's membrane is poorly developed. The endothelium is normal."[7]

Perry notes that, in congenital hereditary endothelial dystrophy, "Histologically, increased diameter of stromal collagen fibrils may produce a thick cornea. Descemet's membrane is thickened in a manner similar to that found with Fuchs' endothelial dystrophy, implying a corneal endothelial abnormality."[7]

In posterior polymorphous dystrophy, Perry notes that, histologically, "Descemet's membrane may be focally or diffusely thickened. Endothelial cells are multilayered and have desmosomes and intracytoplasmic filaments that are characteristic of epithelial cells. A layer of cells may be present beneath the corneal epithelium, but epithelial edema is not common. Iridocorneal adhesions, glassy membranes, and pupillary ectropion, which are changes found in the iridocorneal endothelial syndrome, also may be present in this condition."[7]

Previous
 
 
Contributor Information and Disclosures
Author

Noah S Scheinfeld, MD, JD, FAAD  Assistant Clinical Professor, Department of Dermatology, Columbia University College of Physicians and Surgeons; Consulting Staff, Department of Dermatology, St Luke's Roosevelt Hospital Center, Beth Israel Medical Center, and New York Eye and Ear Infirmary; Private Practice

Noah S Scheinfeld, MD, JD, FAAD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Optigenex Consulting fee Independent contractor

Coauthor(s)

Benjamin D Freilich, MD, FACS  Assistant Clinical Professor, Department of Ophthalmology, Mount Sinai School of Medicine; Director of Retina Service, Bronx Veterans Administration Medical Center

Disclosure: Nothing to disclose.

Jonathan Freilich, MD, FACS  Clinical Instructor, Department of Ophthalmology, Mount Sinai School of Medicine; Consulting Staff, Department of Ophthalmology, Mount Sinai Hospital, St Luke's Roosevelt Hospital Center

Disclosure: Nothing to disclose.

Specialty Editor Board

Richard W Allinson, MD  Associate Professor, Department of Ophthalmology, Texas A&M University Health Science Center; Senior Staff Ophthalmologist, Scott and White Clinic

Richard W Allinson, MD, is a member of the following medical societies: American Academy of Ophthalmology, American Medical Association, and Texas Medical Association

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Christopher J Rapuano, MD  Professor, Department of Ophthalmology, Jefferson Medical College of Thomas Jefferson University; Director of the Cornea Service, Co-Director of Refractive Surgery Department, Wills Eye Institute

Christopher J Rapuano, MD is a member of the following medical societies: American Academy of Ophthalmology, American Society of Cataract and Refractive Surgery, Contact Lens Association of Ophthalmologists, Cornea Society, Eye Bank Association of America, International Society of Refractive Surgery, and Pan-American Association of Ophthalmology

Disclosure: Allergan Honoraria Speaking and teaching; Allergan Consulting fee Consulting; Alcon Honoraria Speaking and teaching; Inspire Honoraria Speaking and teaching; RPS Ownership interest Other; Vistakon Honoraria Speaking and teaching; EyeGate Pharma Consulting; Inspire Consulting fee Consulting; Bausch & Lomb Honoraria Speaking and teaching; Bausch & Lomb Consulting fee Consulting

Ralph Garzia, OD  Assistant Dean for Clinical and Academic Programs, Associate Professor, College of Optometry, University of Missouri at St Louis

Ralph Garzia, OD is a member of the following medical societies: American Academy of Optometry and American Optometric Association

Disclosure: Nothing to disclose.

Chief Editor

Hampton Roy Sr, MD  Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences

Hampton Roy Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, and Pan-American Association of Ophthalmology

Disclosure: Nothing to disclose.

References
  1. Bhat YR, Sanoj KM. Images in Clinical Practices. Sclerocornea. Indian Pediatrics. Mar 17 2005;42:42. [Full Text].

  2. EyeMDLink. Congenital hereditary endothelial dystrophy. Available at http://www.allaboutvision.com/conditions/.

  3. Hand CK, Harmon DL, Kennedy SM, FitzSimon JS, Collum LM, Parfrey NA. Localization of the gene for autosomal recessive congenital hereditary endothelial dystrophy (CHED2) to chromosome 20 by homozygosity mapping. Genomics. Oct 1 1999;61(1):1-4. [Medline].

  4. Miller MM, Butrus S, Hidayat A, Wei LL, Pontigo M. Corneoscleral transplantation in congenital corneal staphyloma and Peters' anomaly. Ophthalmic Genet. Mar 2003;24(1):59-63. [Medline].

  5. Desir J, Abramowicz M. Congenital hereditary endothelial dystrophy with progressive sensorineural deafness (Harboyan syndrome). Orphanet J Rare Dis. Oct 15 2008;3:28. [Medline].

  6. Waizenegger UR, Kohnen T, Weidle EG, Schütte E. [Congenital familial cornea plana with ptosis, peripheral sclerocornea and conjunctival xerosis]. Klin Monatsbl Augenheilkd. Aug 1995;207(2):111-6. [Medline].

  7. Perry HD, Cameron JD. Congenital corneal opacities. Available at http://www.ophthalmic.hyperguides.com.

  8. Bower KS, Edwards JD, Wagner ME, Ward TP, Hidayat A. Novel corneal phenotype in a patient with alport syndrome. Cornea. 2009;28:599-606. [Medline].

  9. Murphy MJ, Polok BK, Schorderet DF, Cleary ML. Essential role for Pbx1 in corneal morphogenesis. Invest Ophthalmol Vis Sci. Feb 2010;51(2):795-803. [Medline]. [Full Text].

  10. Wang KJ, Wang BB, Zhang F, Zhao Y, Ma X, Zhu SQ. Novel beta-crystallin gene mutations in Chinese families with nuclear cataracts. Arch Ophthalmol. Mar 2011;3:337-43. [Medline].

  11. Kao WW, Liu CY. Roles of lumican and keratocan on corneal transparency. Glycoconj J. May-Jun 2002;19(4-5):275-85. [Medline].

  12. Rezende RA, Uchoa UB, Uchoa R, Rapuano CJ, Laibson PR, Cohen EJ. Congenital corneal opacities in a cornea referral practice. Cornea. Aug 2004;23(6):565-70. [Medline].

  13. Bermejo E, Martínez-Frías ML. Congenital eye malformations: clinical-epidemiological analysis of 1,124,654 consecutive births in Spain. Am J Med Genet. Feb 17 1998;75(5):497-504. [Medline].

  14. el-Gilany AH, el-Fedawy S, Tharwat M. Causes of blindness and needs of the blind in Mansoura, Egypt. East Mediterr Health J. Jan 2002;8(1):6-17. [Medline].

  15. Floyd MS, Kwon YH, Shah S, Benson C, Longmuir SQ. Unilateral congenital glaucoma in a child with optic nerve aplasia. J AAPOS. Apr 2011;2:200-2. [Medline].

  16. Hwang JM, Chung DC, Traboulsi EI. A new syndrome of hereditary congenital corneal opacities, cornea guttata, and corectopia. Arch Ophthalmol. Jul 2003;121(7):1053-4. [Medline].

  17. Cibis GW. Congenital glaucoma. J Am Optom Assoc. Sep 1987;58(9):728-33. [Medline].

  18. Edward DP, Li J, Sawaguchi S, Sugar J, Yue BY, Tso MO. Diffuse corneal clouding in siblings with fetal alcohol syndrome. Am J Ophthalmol. Apr 15 1993;115(4):484-93. [Medline].

  19. Aldave AJ, Eagle RC Jr, Streeten BW, Qi J, Raber IM. Congenital corneal opacification in De Barsy syndrome. Arch Ophthalmol. Feb 2001;119(2):285-8. [Medline].

  20. O'Neill JF. The ocular manifestations of congenital infection: a study of the early effect and long-term outcome of maternally transmitted rubella and toxoplasmosis. Trans Am Ophthalmol Soc. 1998;96:813-79. [Medline].

  21. Lin SC, Hu FR, Hou JW, Yao YT, Wang TR, Hung PT. Corneal opacity and congenital glaucoma associated with massive heparan sulfaturia: report of one case. Acta Paediatr Taiwan. Jan-Feb 1999;40(1):46-9. [Medline].

  22. Kottler U, Demir D, Schmidtmann I, Beck M, Pitz S. Central corneal thickness in mucopolysaccharidosis II and VI. Cornea. Mar 2010;29(3):260-2. [Medline].

  23. Kim T, Cohen EJ, Schnall BM, Affel EL, Eagle RC Jr. Ultrasound biomicroscopy and histopathology of sclerocornea. Cornea. Jul 1998;17(4):443-5. [Medline].

  24. Reidy JJ. Penetrating keratoplasty in infancy and early childhood. Curr Opin Ophthalmol. Aug 2001;12(4):258-61. [Medline].

  25. Michaeli A, Markovich A, Rootman DS. Corneal transplants for the treatment of congenital corneal opacities. J Pediatr Ophthalmol Strabismus. Jan-Feb 2005;42(1):34-44. [Medline].

  26. Al-Torbak AA. Outcome of combined Ahmed glaucoma valve implant and penetrating keratoplasty in refractory congenital glaucoma with corneal opacity. Cornea. Aug 2004;23(6):554-9. [Medline].

  27. Miller MM, Butrus S, Hidayat A, Wei LL, Pontigo M. Corneoscleral transplantation in congenital corneal staphyloma and Peters' anomaly. Ophthalmic Genet. Mar 2003;24(1):59-63. [Medline].

  28. Mandal AK, Gothwal VK, Bagga H, Nutheti R, Mansoori T. Outcome of surgery on infants younger than 1 month with congenital glaucoma. Ophthalmology. Oct 2003;110(10):1909-15. [Medline].

  29. Frueh BE, Brown SI. Transplantation of congenitally opaque corneas. Br J Ophthalmol. Dec 1997;81(12):1064-9. [Medline].

  30. Bredrup C, Knappskog PM, Majewski J, Rodahl E, Boman H. Congenital stromal dystrophy of the cornea caused by a mutation in the decorin gene. Invest Ophthalmol Vis Sci. Feb 2005;46(2):420-6. [Medline].

  31. Cassidy L. Paediatric cataract. March 9 2001. optometrytoday. Available at http://www.optometry.co.uk/files/e8cf2c379b358b7d42e25bdfa54a9abf_cassidy20010309.pdf. Accessed March 12, 2011.

  32. Cibis GW, Waeltermann J, Harris DJ. Peters' anomaly in association with ring 21 chromosomal abnormality. Am J Ophthalmol. Nov 15 1985;100(5):733-4. [Medline].

  33. Ciralsky J, Colby K. Congenital corneal opacities: a review with a focus on genetics. Semin Ophthalmol. Oct-Dec 2007;22:241-6. [Medline].

  34. Duke-Elder S. Congenital deformities. In: System of Ophthalmology. Vol III. St Louis: Mosby; 1965.

  35. Hansen L, Eiberg H, Rosenberg T. Novel MAF mutation in a family with congenital cataract-microcornea syndrome. Mol Vis. Oct 18 2007;13:2019-22. [Medline].

  36. Hansen L, Yao W, Eiberg H, Kjaer KW, Baggesen K, Hejtmancik JF, et al. Genetic heterogeneity in microcornea-cataract: five novel mutations in CRYAA, CRYGD, and GJA8. Invest Ophthalmol Vis Sci. Sep 2007;48(9):3937-44. [Medline].

  37. Holmberg J, Liu CY, Hjalt TA. PITX2 gain-of-function in Rieger syndrome eye model. Am J Pathol. Nov 2004;165(5):1633-41. [Medline].

  38. Parthasarathy A, Naumann GO. Coexistent congenital hereditary endothelial dystrophy and congenital glaucoma. Cornea. Apr 2009;28(3):365; author reply 365-6. [Medline].

  39. Sherman MD. Dermoids, Limbal. eMedicine Journal [serial online]. 2010;Available at http://emedicine.medscape.com/article/1195334-overview.

  40. Stone DU, Siatkowski RM. Congenital retinal dystrophy and corneal opacity in trisomy 8 mosaicism. J AAPOS. Jun 2005;9(3):290-1. [Medline].

  41. Tewfik TL. Manifestations of Craniofacial Syndromes. eMedicine Journal [serial online]. 2010;Available at http://emedicine.medscape.com/article/844209-overview.

  42. Thiagalingam S, Jakobiec FA, Chen T, Michaud N, Colby KA, Walton DS. Corneal anomalies in newborn primary congenital glaucoma. J Pediatr Ophthalmol Strabismus. Jul-Aug 2009;46(4):241-4. [Medline].

  43. Wimplinger I, Shaw GM, Kutsche K. HCCS loss-of-function missense mutation in a female with bilateral microphthalmia and sclerocornea: a novel gene for severe ocular malformations?. Mol Vis. Aug 27 2007;13:1475-82. [Medline].

  44. Zaidman GW. The use of CT scanning in the diagnosis of protuberant congenital corneal opacities. J Pediatr Ophthalmol Strabismus. Mar-Apr 1999;36(2):101-2. [Medline].

Previous
Next
 
Clouding of the cornea since childhood.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.